Beigene Eulerpool Ziņas

Beigene Eulerpool News

Beigene Akciju Ziņas

Beigene tiek uzmanīgi vēroti no žurnālistu un investoru puses visā pasaulē. Jaunākās Beigene ziņas mēs apkopojam šeit.

• 4. oktobris ·

  GuruFocus
  Chinese Biopharmaceutical Stocks Surge with Positive Policy Impact
• 27. septembris ·

  SeekingAlpha
  Zymeworks Approaching A Moment Of Truth With Zanidatamab
• 27. septembris ·

  Yahoo
  3 Stocks That May Be Trading Below Intrinsic Value By Up To 48.2%
• 27. septembris ·

  Yahoo
  BeiGene Provides Update on FDA Advisory Committee Vote on Benefit-Risk Profile of PD-1 Inhibitors, including TEVIMBRA®, for Treatment of ESCC and Gastric/GEJ Cancers
• 26. septembris ·

  Business Wire
  BeiGene Provides Update on FDA Advisory Committee Vote on Benefit-Risk Profile of PD-1 Inhibitors, including TEVIMBRA?, for Treatment of ESCC and Gastric/GEJ Cancers
• 26. septembris ·

  Seeking Alpha
  Merck, Bristol-Myers fail to convince FDA AdCom on wider Opdivo, Keytruda use
• 26. septembris ·

  Yahoo
  Global Oncology Innovator BeiGene Appoints Shalini Sharp to Board of Directors
• 26. septembris ·

  Thefly.com
  BeiGene says FDA's ODAC sees favorable benefit-risk profile of PD-1 inhibitors
• 25. septembris ·

  Yahoo
  FDA Casts Doubt On Use Of Merck, Bristol Myers' PD-1 Cancer Drugs For Certain Type Of Gastric Cancer Patients
• 24. septembris ·

  Seeking Alpha
  Bristol, Merck checkpoint inhibitors focus of FDA advisory committee meeting